• <em>DIS3</em> depletion in multiple myeloma causes extensive perturbation in cell cycle progression and centrosome amplification
• <em>RB1</em> loss overrides PARP inhibitor sensitivity driven by <em>RNASEH2B</em> loss in prostate cancer
• 11p15 duplication and 13q34 deletion with Beckwith-Wiedemann syndrome and factor VII deficiency
• 13q Deletion Syndrome Involving <em>RB1</em>: Characterization of a New Minimal Critical Region for Psychomotor Delay
• 13q Deletion Syndrome Involving RB1: Characterization of a New Minimal Critical Region for Psychomotor Delay
• 13q deletion syndrome resulting from balanced chromosomal rearrangement in father: the significance of parental karyotyping
• 13q mosaic deletion including <em>RB1</em> associated to mild phenotype and no cancer outcome - case report and review of the literature
• 13q12.2 deletions in acute lymphoblastic leukemia lead to upregulation of FLT3 through enhancer hijacking
• 13q13.3 microdeletion associated with apparently balanced translocation of 46,XX,t(7;13) suggests NBEA involvement
• 13q14 Deletion and Its Effect on Prognosis of Chronic Lymphocytic Leukemia
• 16p13.11 microdeletion in a patient with hemiconvulsion-hemiplegia-epilepsy syndrome: a case report
• 22.5 MB DELETION OF 13q31.1-q34 ASSOCIATED WITH HPE, DWM, AND HSCR: A CASE REPORT AND REDEFINING THE SMALLEST DELETED REGIONS
• 3p partial trisomy and 13q partial monosomy with congenital malformations and psychomotor developmental delay
• A de novo 13q31.3 microduplication encompassing the miR-17 ~ 92 cluster results in features mirroring those associated with Feingold syndrome 2
• A female patient with retinoblastoma and severe intellectual disability carrying an X;13 balanced translocation without rearrangement in the RB1 gene: a case report
• A higher percentage of cells with 13q deletion predicts worse outcome in Chinese patients with chronic lymphocytic leukemia carrying isolated 13q deletion
• A large fraction of trisomy 12, 17p^-, and 11q^- CLL cases carry unidentified microdeletions of <em>miR-15a/16-1</em>
• A NEW OBSERVATION OF 13q DELETION SYNDROME: SEVERE UNDESCRIBED FEATURES
• A new variable phenotype in spinocerebellar ataxia 27 (SCA 27) caused by a deletion in the FGF14 gene
• A novel human multiple myeloma cell line with a 1q21 gain genetic abnormality and CKS1B overexpression
• A Rare Co-occurrence of Intestinal Malrotation and Hirschsprung's Disease in a Neonate with 13q21.31q33.1 Interstitial Deletion Including the <em>EDNRB</em> Gene
• A rare unbalanced translocation (trisomy 5q33.3-qter, monosomy 13q34-qter) results in growth hormone deficiency and brain anomalies
• Acquired retinal pigmentary degeneration in a child with 13q deletion syndrome
• Acute Orbital Compromise after Intra-Arterial Chemotherapy in a Complex Retinoblastoma Associated with 13q Deletion Syndrome
• An Anomaly with Potential as a New Prognostic Marker in CLL with del(13q): Gain of 16p13.3
• Auer rod-like inclusions in κ light chain myeloma
• BCL2 and miR-15/16: from gene discovery to treatment
• Bilateral Cleft Lip and Palate Accompanied by 13q- Syndrome with Deficiencies of FVII and FX: A Case Report
• Blake's pouch cyst in 13q deletion syndrome: Posterior fossa malformations may occur due to disruption of multiple genes
• Characterization of CD34-deficient myofibroblastomas of the breast
• Chromosome 13q deletion syndrome involving 13q31-qter: A case report
• Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations
• Cochlear implantation in 13q deletion syndrome
• Copy-number intratumor heterogeneity increases the risk of relapse in chemotherapy-naive stage II colon cancer
• CTCF loss induces giant lamellar bodies in Purkinje cell dendrites
• Cytogenetic Abnormalities in Multiple Myeloma Patients at a Tertiary Healthcare Center in India
• Dasatinib-responsive chronic lymphocytic leukemia in a patient treated for coexisting chronic myeloid leukemia
• De novo 13q deletions in two patients with mild anorectal malformations as part of VATER/VACTERL and VATER/VACTERL-like association and analysis of EFNB2 in patients with anorectal malformations
• De novo 13q13.3-21.31 deletion involving RB1 gene in a patient with hemangioendothelioma of the liver
• Deletion of Chromosome 13 due to Different Rearrangements and Impact on Phenotype
• Digital Gangrene and Antiphospholipid Syndrome in a Retinoblastoma Patient with Chromosome 13q Deletion: A Case Report
• Dissecting chronic lymphocytic leukemia with 13q- using microRNA expression profile: Editorial for the paper "MiRNA expression profile of chronic lymphocytic leukemia patients with 13q deletion"
• Distal 13q monosomy and neural tube defects
• Early-Onset Diabetes Mellitus in a Patient With a Chromosome 13q34qter Microdeletion Including <em>IRS2</em>
• Effect of 13q deletion on IL-6 production in patients with multiple myeloma: a hypothesis may hold true
• EFNB2 haploinsufficiency causes a syndromic neurodevelopmental disorder
• Evaluation of Second Primary Cancer Risk Among Chronic Lymphocytic Leukemia Patients: Multicenter Study
• Fold-back mechanism originating inv-dup-del rearrangements in chromosomes 13 and 15
• Frequency, variations, and prognostic implications of chromosome 14q32 deletions in chronic lymphocytic leukemia
• From Genes to Ambiguity: A Case Study Exploring the Enigmatic Connection Between Chromosome 13q Deletion Syndrome and Ambiguous Genitalia
• Generation of a human induced pluripotent stem cells (MUi015-A) from skin fibroblast of retinoblastoma patient with 13q deletion syndrome
• Generation of induced pluripotent stem cells derived from primary and secondary myelofibrosis patient samples
• Genetic analysis of a child with 13q deletion syndrome featuring congenital heart disease
• Genetic testing in infantile spasms identifies a chromosome 13q deletion and retinoblastoma
• Genomic and Clinicopathologic Features of Primary Myelofibrosis With Isolated 13q Deletion
• Holoprosencephaly with cerebellar vermis hypoplasia in 13q deletion syndrome: Critical region for cerebellar dysgenesis within 13q32.2q34
• Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia
• Hypergranular multiple myeloma with crystalline inclusions in young with 13q deletion
• Identification and monitoring of Copy Number Variants (CNV) in monoclonal gammopathy
• Identification of partial trisomy 13q in two unrelated patients using single-nucleotide polymorphism array and literature overview
• IGH Translocations in Chinese Patients With Chronic Lymphocytic Leukemia: Clinicopathologic Characteristics and Genetic Profile
• Inversion duplication deletions involving the long arm of chromosome 13: phenotypic description of additional three fetuses and genotype-phenotype correlation
• Iris Hypoplasia as the Presenting Sign of Retinoblastoma in a Child With a 13q Deletion
• Jumping-like translocation-a rare chromosomal rearrangement in a patient with Burkitt lymphoma/leukemia
• Long-read genome sequencing resolves a complex 13q structural variant associated with syndromic anophthalmia
• Loss of a chromosomal region with synteny to human 13q14 occurs in mouse chronic lymphocytic leukemia that originates from early-generated B-1 B cells
• Magic mirror in my hand, which is the lineage in the end? A case of acute leukemia with hand-mirror cells
• miR-15a/16-1 deletion in activated B cells promotes plasma cell and mature B-cell neoplasms
• MiRNA expression profile of chronic lymphocytic leukemia patients with 13q deletion
• Molecular diagnosis in patients with retinoblastoma: Report of a series of cases
• Monosomy 13 in Mammary Myofibroblastoma
• Myofibroblastoma of the breast showing rare palisaded morphology and uncommon desmin- and CD34-negative immunophenotype: A case report
• Myofibroblastoma of the breast with smooth muscle differentiation showing deletion of 13q14 region: report of a case
• Onychomatricoma: a clinicopathological, immunohistochemical, and molecular study of 10 cases highlighting recurrent RB1 deletion and the potential diagnostic value of LEF-1
• Ophthalmological manifestations of 13q deletion syndrome: A case report
• Partial Trisomy 13q/Monosomy 3p Resulting from a Paternal Reciprocal 3p;13q Translocation in a Boy with Facial Dysmorphism and Hypertrophic Cardiomyopathy
• Patients with retinoblastoma and chromosome 13q deletions have increased chemotherapy-related toxicities
• Pediatric combined hepatocellular-cholangiocarcinoma (cHCC-CC) with neuroendocrine features: distinguishing genetic alterations detected by chromosomal microarray
• Phenotypical characterization of 13q deletion syndrome: Report of two cases
• Postnatal diagnosis of constitutive ring chromosome 13 using both conventional and molecular cytogenetic approaches
• Prenatal detection of chromosomal abnormalities and copy number variants in fetuses with congenital gastrointestinal obstruction
• Prenatal diagnosis and genetic counselling for a pedigree carrying a large fragment deletion of 13q
• Prenatal diagnosis and molecular cytogenetic characterization of mosaicism for r(13), monosomy 13 and idic r(13) by amniocentesis
• Prenatal diagnosis of distal 13q deletion syndrome in a fetus with esophageal atresia: a case report and review of the literature
• Prenatal diagnosis of recurrent mosaic ring chromosome 13 of maternal origin
• Prenatal Sonographic Features of Rare Chromosome 13 Aberrations
• Recurrent Sporadic Bilateral Retinoblastoma in a Child with 13q Deletion Syndrome
• Reduced anogenital distance, hematuria and left renal hypoplasia in a patient with 13q33.1-34 deletion: case report and literature review
• Retinoblastoma
• Retinoblastoma and mosaic 13q deletion: a case report
• Retinoblastoma and polydactyly in a child with 46, XY, 15pstk+ karyotype-A case report and literature review
• Retinoblastoma in Patients with 13q deletion syndrome - case series
• Retinoblastoma management in 13q deletion syndrome patients using super-selective chemotherapies and other cancer-directed interventions
• Risk stratification in multiple myeloma, part 2: the significance of genetic risk factors in the era of currently available therapies
• The added value of karyotype in predicting the need for therapy in chronic lymphocytic leukemia with 13q deletion
• The clinical characteristics and prognosis of IGH deletion in multiple myeloma
• The Landscape of Cytogenetic Aberrations in Light-Chain Amyloidosis with or without Coexistent Multiple Myeloma
• The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trial
• Tourette syndrome, obsessive compulsive behavior, and dysmorphic features in a patient with deletions at chromosome 18q22.1 and chromosome 13q12.3-q13.1
• Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution